EVP, Chief Revenue Officer of BDX
EVP, CRO & Pres. Life Sciences of BDX
EVP & President, Life Sciences of BDX
EVP, Chief Revenue Officer
Avg Cost/Share
$181.84
Shares
75
Total Value
$13,638.00
Owned After
21,308
SEC Form 4
EVP, CRO & Pres. Life Sciences
Avg Cost/Share
$202.73
Shares
75
Total Value
$15,204.75
Owned After
21,308
SEC Form 4
EVP, CRO & Pres. Life Sciences
Avg Cost/Share
$196.08
Shares
74
Total Value
$14,509.92
Owned After
21,308
SEC Form 4
EVP, CRO & Pres. Life Sciences
Avg Cost/Share
$193.36
Shares
75
Total Value
$14,502.00
Owned After
21,308
SEC Form 4
EVP & President, Life Sciences
Avg Cost/Share
$186.01
Shares
57
Total Value
$10,602.57
Owned After
21,308
SEC Form 4
EVP & President, Life Sciences
Avg Cost/Share
$181.03
Shares
58
Total Value
$10,499.74
Owned After
21,308
SEC Form 4
EVP & President, Life Sciences
Avg Cost/Share
$197.99
Shares
57
Total Value
$11,285.43
Owned After
21,308
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Feld Michael | BDX | EVP, Chief Revenue Officer | Feb 26, 2026 | Sell | $181.84 | 75 | $13,638.00 | 21,308 | |
| Feld Michael | BDX | EVP, CRO & Pres. Life Sciences | Jan 26, 2026 | Sell | $202.73 | 75 | $15,204.75 | 21,308 | |
| Feld Michael | BDX | EVP, CRO & Pres. Life Sciences | Dec 26, 2025 | Sell | $196.08 | 74 | $14,509.92 | 21,308 | |
| Feld Michael | BDX | EVP, CRO & Pres. Life Sciences | Dec 1, 2025 | Sell | $193.36 | 75 | $14,502.00 | 21,308 | |
| Feld Michael | BDX | EVP & President, Life Sciences | Oct 27, 2025 | Sell | $186.01 | 57 | $10,602.57 | 21,308 | |
| Feld Michael | BDX | EVP & President, Life Sciences | Sep 26, 2025 | Sell | $181.03 | 58 | $10,499.74 | 21,308 | |
| Feld Michael | BDX | EVP & President, Life Sciences | Aug 22, 2025 | Sell | $197.99 | 57 | $11,285.43 | 21,308 |